Curis Inc has reported their CA-4948 treatment has shown an overall tumor decrease of >20% from baseline. Downstream pharmacodynamic markers…
Read MoreCuris Inc has reported their CA-4948 treatment has shown an overall tumor decrease of >20% from baseline. Downstream pharmacodynamic markers…
Read More